🔬 CJC-1295 No DAC + Ipamorelin – 10mg Research Blend
This blend contains two distinct research peptides—CJC-1295 No DAC and Ipamorelin—each supplied at 5mg for a combined 10mg per vial. Both components are provided as lyophilized powders suitable for controlled laboratory analysis within neuroendocrine and receptor-interaction model systems.
Lyophilized powder supplied in standard laboratory vials.
Not for injection. Not for clinical or therapeutic use.
📌 Product Specifications
- Form: Lyophilized powder
- Amount: 10mg total (5mg CJC-1295 No DAC + 5mg Ipamorelin)
- Purity: ≥ 98%
- Appearance: White to off-white powder
🧪 Molecular Information
- CJC-1295 No DAC Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gly-Ser
- Ipamorelin Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
- CAS (CJC-1295 No DAC): 863288-34-0
- CAS (Ipamorelin): 170851-70-4
🔬 Research Applications
- Studies involving growth hormone secretagogue model systems
- Receptor pathway evaluation for GHRH and GHRP classes
- Neuroendocrine and hypothalamic signaling investigations
📦 Storage
Store lyophilized material in a cool, dry environment. After reconstitution, refrigerate for short-term stability. For extended storage, freezing is recommended.
CJC-1295 No DAC + Ipamorelin Blend – Research FAQ
This FAQ provides structured technical information regarding the laboratory application, receptor pathway interaction, and experimental handling of the CJC-1295 No DAC and Ipamorelin peptide blend.
1. What is the purpose of combining CJC-1295 No DAC with Ipamorelin in research?
This blend is used in laboratory models to study complementary peptide activity within growth hormone signalling pathways. CJC-1295 No DAC targets GHRH receptor pathways, while Ipamorelin is associated with GHRP receptor interaction, allowing researchers to evaluate combined signalling effects in controlled environments.
2. How does the absence of DAC in CJC-1295 affect experimental outcomes?
The non-DAC version has a shorter activity window compared to DAC-modified forms. This makes it more suitable for studies requiring precise timing, pulse-response evaluation, and short-duration signalling analysis.
3. What types of receptor pathways are analysed using this peptide blend?
Researchers use this combination to investigate GHRH and GHRP receptor pathways, particularly in neuroendocrine and hypothalamic signalling models. It is useful for studying how different receptor classes interact within regulated experimental systems.
4. How should the CJC-1295 No DAC + Ipamorelin blend be reconstituted and stored?
The lyophilised powder should be reconstituted using appropriate laboratory solvents under controlled conditions. After reconstitution, it should be refrigerated for short-term use, while freezing is recommended for extended storage to maintain stability.
5. What makes this peptide blend suitable for controlled laboratory studies?
The standardised 5mg/5mg composition and ≥98% purity ensure consistent measurement and reproducibility. This allows researchers to design structured experiments with reliable dosing and minimal variability across trials.

